- Home
- PRCH vs EVMN Comparison
PRCH vs EVMN Comparison
Compare PRCH & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRCH | EVMN |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 880.9M | 892.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRCH | EVMN |
|---|---|---|
| Price | $7.10 | $23.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $17.11 | ★ $43.29 |
| AVG Volume (30 Days) | ★ 1.2M | 286.3K |
| Earning Date | 05-05-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $482,414,000.00 | N/A |
| Revenue This Year | $3.86 | N/A |
| Revenue Next Year | $16.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.18 | N/A |
| 52 Week Low | $4.65 | $13.89 |
| 52 Week High | $19.44 | $33.20 |
Technical Indicators
Market Signals| Indicator | PRCH | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 40.36 | 46.53 |
| Support Level | $6.36 | $21.40 |
| Resistance Level | $9.89 | $33.20 |
| Average True Range (ATR) | 0.42 | 2.08 |
| MACD | -0.05 | -0.36 |
| Stochastic Oscillator | 3.16 | 33.61 |
Price Performance
Historical ComparisonAbout PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.